A citation-based method for searching scientific literature

Johanna Flach, Evgenii Shumilov, Raphael Joncourt, Naomi Porret, Urban Novak, Thomas Pabst, Ulrike Bacher. Crit Rev Oncol Hematol 2020
Times Cited: 13







List of co-cited articles
38 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Current status and trends in the diagnostics of AML and MDS.
Evgenii Shumilov, Johanna Flach, Alexander Kohlmann, Yara Banz, Nicolas Bonadies, Martin Fiedler, Thomas Pabst, Ulrike Bacher. Blood Rev 2018
25
23

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.
Hartmut Döhner, Elihu Estey, David Grimwade, Sergio Amadori, Frederick R Appelbaum, Thomas Büchner, Hervé Dombret, Benjamin L Ebert, Pierre Fenaux, Richard A Larson,[...]. Blood 2017
23


Digital PCR in Myeloid Malignancies: Ready to Replace Quantitative PCR?
Daniela Cilloni, Jessica Petiti, Valentina Rosso, Giacomo Andreani, Matteo Dragani, Carmen Fava, Giuseppe Saglio. Int J Mol Sci 2019
26
15

Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCR.
Daniela Drandi, Lenka Kubiczkova-Besse, Simone Ferrero, Nadia Dani, Roberto Passera, Barbara Mantoan, Manuela Gambella, Luigia Monitillo, Elona Saraci, Paola Ghione,[...]. J Mol Diagn 2015
90
15

Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paper.
Simona Soverini, Elisabetta Abruzzese, Monica Bocchia, Massimiliano Bonifacio, Sara Galimberti, Antonella Gozzini, Alessandra Iurlo, Luigiana Luciano, Patrizia Pregno, Gianantonio Rosti,[...]. J Hematol Oncol 2019
23
15

Next-generation sequencing for minimal residual disease monitoring in acute myeloid leukemia patients with FLT3-ITD or NPM1 mutations.
Felicitas Thol, Britta Kölking, Frederik Damm, Katarina Reinhardt, Jan-Henning Klusmann, Dirk Reinhardt, Nils von Neuhoff, Martijn H Brugman, Brigitte Schlegelberger, Sebastian Suerbaum,[...]. Genes Chromosomes Cancer 2012
83
15

Myeloma MRD by deep sequencing from circulating tumor DNA does not correlate with results obtained in the bone marrow.
Céline Mazzotti, Laure Buisson, Sabrina Maheo, Aurore Perrot, Marie-Lorraine Chretien, Xavier Leleu, Cyrille Hulin, Salomon Manier, Benjamin Hébraud, Murielle Roussel,[...]. Blood Adv 2018
47
15

Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas.
S Hohaus, M Giachelia, G Massini, G Mansueto, B Vannata, V Bozzoli, M Criscuolo, F D'Alò, M Martini, L M Larocca,[...]. Ann Oncol 2009
82
15

Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma.
J Flores-Montero, L Sanoja-Flores, B Paiva, N Puig, O García-Sánchez, S Böttcher, V H J van der Velden, J-J Pérez-Morán, M-B Vidriales, R García-Sanz,[...]. Leukemia 2017
309
15

Heterogeneity of genomic evolution and mutational profiles in multiple myeloma.
Niccolo Bolli, Hervé Avet-Loiseau, David C Wedge, Peter Van Loo, Ludmil B Alexandrov, Inigo Martincorena, Kevin J Dawson, Francesco Iorio, Serena Nik-Zainal, Graham R Bignell,[...]. Nat Commun 2014
582
15

Monitoring multiple myeloma by quantification of recurrent mutations in serum.
Even Holth Rustad, Eivind Coward, Emilie R Skytøen, Kristine Misund, Toril Holien, Therese Standal, Magne Børset, Vidar Beisvag, Ola Myklebost, Leonardo A Meza-Zepeda,[...]. Haematologica 2017
35
15


DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells.
S Jahr, H Hentze, S Englisch, D Hardt, F O Fackelmayer, R D Hesch, R Knippers. Cancer Res 2001
15

Circulating tumor DNA as a liquid biopsy in plasma cell dyscrasias.
Bernhard Gerber, Martina Manzoni, Valeria Spina, Alessio Bruscaggin, Marta Lionetti, Sonia Fabris, Marzia Barbieri, Gabriella Ciceri, Alessandra Pompa, Gabriela Forestieri,[...]. Haematologica 2018
22
15

Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients.
S K Kumar, A Dispenzieri, M Q Lacy, M A Gertz, F K Buadi, S Pandey, P Kapoor, D Dingli, S R Hayman, N Leung,[...]. Leukemia 2014
879
15

Noninvasive Molecular Monitoring in Multiple Myeloma Patients Using Cell-Free Tumor DNA: A Pilot Study.
Giulia Biancon, Silvia Gimondi, Antonio Vendramin, Cristiana Carniti, Paolo Corradini. J Mol Diagn 2018
25
15

Limits and Applications of Genomic Analysis of Circulating Tumor DNA as a Liquid Biopsy in Asymptomatic Forms of Multiple Myeloma.
Martina Manzoni, Alessandra Pompa, Sonia Fabris, Francesca Pelizzoni, Gabriella Ciceri, Manuela Seia, Bachisio Ziccheddu, Niccolò Bolli, Paolo Corradini, Luca Baldini,[...]. Hemasphere 2020
10
20

Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma.
S Manier, J Park, M Capelletti, M Bustoros, S S Freeman, G Ha, J Rhoades, C J Liu, D Huynh, S C Reed,[...]. Nat Commun 2018
101
15

Blood platelets contain tumor-derived RNA biomarkers.
R Jonas A Nilsson, Leonora Balaj, Esther Hulleman, Sjoerd van Rijn, D Michiel Pegtel, Maudy Walraven, Anders Widmark, Winald R Gerritsen, Henk M Verheul, W Peter Vandertop,[...]. Blood 2011
208
15

Genetic interrogation of circulating multiple myeloma cells at single-cell resolution.
Jens G Lohr, Sora Kim, Joshua Gould, Birgit Knoechel, Yotam Drier, Matthew J Cotton, Daniel Gray, Nicole Birrer, Bang Wong, Gavin Ha,[...]. Sci Transl Med 2016
93
15

The utility of non-invasive liquid biopsy for mutational analysis and minimal residual disease assessment in extramedullary multiple myeloma.
Xiaolu Long, Qian Xu, Yaoyao Lou, Chunrui Li, Jia Gu, Haodong Cai, Di Wang, Jinhuan Xu, Tongjuan Li, Xiaoxi Zhou,[...]. Br J Haematol 2020
10
20

Genomic discovery and clonal tracking in multiple myeloma by cell-free DNA sequencing.
Guangwu Guo, Noopur S Raje, Charles Seifer, Jake Kloeber, Randi Isenhart, Gavin Ha, Andrew J Yee, Elizabeth K O'Donnell, Yu-Tzu Tai, Paul G Richardson,[...]. Leukemia 2018
30
15

Monitoring Plasma Cell Dyscrasias With Cell-free DNA Analysis.
Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Evangelos Terpos, Despoina Fotiou, Efstathios Kastritis, Meletios A Dimopoulos. Clin Lymphoma Myeloma Leuk 2020
6
33

Circulating tumour DNA analysis demonstrates spatial mutational heterogeneity that coincides with disease relapse in myeloma.
S Mithraprabhu, T Khong, M Ramachandran, A Chow, D Klarica, L Mai, S Walsh, D Broemeling, A Marziali, M Wiggin,[...]. Leukemia 2017
67
15

Enumeration and characterization of circulating multiple myeloma cells in patients with plasma cell disorders.
Brad Foulk, Mike Schaffer, Steve Gross, Chandra Rao, Denis Smirnov, Mark C Connelly, Shalini Chaturvedi, Manjula Reddy, Greg Brittingham, Marielena Mata,[...]. Br J Haematol 2018
25
15


Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates.
Olena Kis, Rayan Kaedbey, Signy Chow, Arnavaz Danesh, Mark Dowar, Tiantian Li, Zhihua Li, Jessica Liu, Mark Mansour, Esther Masih-Khan,[...]. Nat Commun 2017
74
15

Nuclear Acids In Human Blood Plasma.
P MANDEL, P METAIS. C R Seances Soc Biol Fil 1948
617
15

Dynamics of tumor-specific cfDNA in response to therapy in multiple myeloma patients.
David Vrabel, Lenka Sedlarikova, Lenka Besse, Lucie Rihova, Renata Bezdekova, Martina Almasi, Veronika Kubaczkova, Lucie Brožová, Jiri Jarkovsky, Hana Plonkova,[...]. Eur J Haematol 2020
12
16

Monitoring multiple myeloma by next-generation sequencing of V(D)J rearrangements from circulating myeloma cells and cell-free myeloma DNA.
Anna Oberle, Anna Brandt, Minna Voigtlaender, Benjamin Thiele, Janina Radloff, Anita Schulenkorf, Malik Alawi, Nuray Akyüz, Manuela März, Christopher T Ford,[...]. Haematologica 2017
70
15

Monitoring treatment response and disease progression in myeloma with circulating cell-free DNA.
Shayu Deshpande, Ruslana G Tytarenko, Yan Wang, Eileen M Boyle, Cody Ashby, Carolina D Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, Fenghuang Zhan, Faith E Davies,[...]. Eur J Haematol 2021
7
28


Role of cell-free DNA in haematological malignancies.
Jun K Lim, Bryone Kuss, Dipti Talaulikar. Pathology 2021
4
50

Tracking myeloma tumor DNA in peripheral blood.
Johannes M Waldschmidt, Tushara Vijaykumar, Birgit Knoechel, Jens G Lohr. Best Pract Res Clin Haematol 2020
3
66

Detection and Characterization of Circulating Tumour Cells in Multiple Myeloma.
Liangxuan Zhang, Sharon Beasley, Natalie L Prigozhina, Renee Higgins, Shoji Ikeda, Florence Y Lee, Dena Marrinucci, Shidong Jia. J Circ Biomark 2016
10
20

Quantification of free total plasma DNA and minimal residual disease detection in the plasma of children with acute lymphoblastic leukemia.
Arne Kristian Schwarz, Martin Stanulla, Gunnar Cario, Thomas Flohr, Rosemary Sutton, Anja Möricke, Philippe Anker, Maurice Stroun, Karl Welte, Claus R Bartram,[...]. Ann Hematol 2009
18
15


The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate.
Patrick S Ward, Jay Patel, David R Wise, Omar Abdel-Wahab, Bryson D Bennett, Hilary A Coller, Justin R Cross, Valeria R Fantin, Cyrus V Hedvat, Alexander E Perl,[...]. Cancer Cell 2010
7


Hyperpolarized (13)C MR imaging detects no lactate production in mutant IDH1 gliomas: Implications for diagnosis and response monitoring.
Myriam M Chaumeil, Marina Radoul, Chloé Najac, Pia Eriksson, Pavithra Viswanath, Michael D Blough, Charles Chesnelong, H Artee Luchman, J Gregory Cairncross, Sabrina M Ronen. Neuroimage Clin 2016
36
7

Transaminase Inhibition by 2-Hydroxyglutarate Impairs Glutamate Biosynthesis and Redox Homeostasis in Glioma.
Samuel K McBrayer, Jared R Mayers, Gabriel J DiNatale, Diana D Shi, Januka Khanal, Abhishek A Chakraborty, Kristopher A Sarosiek, Kimberly J Briggs, Alissa K Robbins, Tomasz Sewastianik,[...]. Cell 2018
148
7


Six-gene signature for predicting survival in patients with head and neck squamous cell carcinoma.
Juncheng Wang, Xun Chen, Yuxi Tian, Gangcai Zhu, Yuexiang Qin, Xuan Chen, Leiming Pi, Ming Wei, Guancheng Liu, Zhexuan Li,[...]. Aging (Albany NY) 2020
35
7

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
7

Lipidomic approach for stratification of acute myeloid leukemia patients.
Adam Stefanko, Christian Thiede, Gerhard Ehninger, Kai Simons, Michal Grzybek. PLoS One 2017
24
7

Identification of Escherichia coli by detection of hydroquinone and uracil in the urine system.
K Maeda, S Shiraishi, N Sakamoto, T Ohki, M Hosoi, K Ohta, N Yamanaka. J Chromatogr 1985
4
25

Metabolomics analysis identifies lysine and taurine as candidate prognostic biomarkers for AML-M2 patients.
Xuan Zhou, Meihong Zheng, Qien Wang, Jiye Aa, Bei Cao, Juan Li. Int J Hematol 2020
8
12


The Interactions Between Diabetes Mellitus and Myelodysplastic Syndromes: Current State of Evidence and Future Directions.
Eyad Hamoudeh, Amer M Zeidan, Lisa Barbarotta, Nina Rosano. Curr Diabetes Rev 2016
6
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.